meta:
  schema_version: '1.0'
  generated_by: Dawn (literature curation)
  last_updated: '2026-02-13'
  compatible_engine: cellswarm>=2.0
pathway_id: IL2_STAT5
pathway_name: IL-2/JAK-STAT5 Signaling
category: cytokine_signaling
kegg_id: hsa04630
components:
  receptors:
  - IL2RA
  - IL2RB
  - IL2RG
  ligands:
  - IL2
  downstream:
  - JAK1
  - JAK3
  - STAT5A
  - STAT5B
  - PI3K
  - AKT
  transcription_factors:
  - STAT5A
  - STAT5B
  key_genes:
  - IL2
  - IL2RA
  - IL2RB
  - JAK1
  - JAK3
  - STAT5A
  - STAT5B
signal_fields_affected:
- IL2
cell_type_effects:
  CD8_T:
    when_active: IL-2 promotes CD8+ T cell proliferation, survival, and effector differentiation.
      Essential for clonal expansion.
    behavioral_mapping:
      proliferate: 0.25
      attack: 0.1
      signal: 0.05
    state_effects:
      activation: 0.15
      energy: 0.1
  Treg:
    when_active: Tregs constitutively express high-affinity IL-2R (CD25). IL-2 is
      essential for Treg survival and suppressive function. Tregs act as IL-2 sinks.
    behavioral_mapping:
      suppress: 0.25
      proliferate: 0.15
    state_effects:
      suppressive_activity: 0.2
      activation: 0.15
  NK:
    when_active: IL-2 activates NK cells, enhancing cytotoxicity and proliferation.
    behavioral_mapping:
      attack: 0.15
      proliferate: 0.1
    state_effects:
      activation: 0.15
      cytotoxicity: 0.1
  Tumor:
    when_active: Minimal direct effect on most tumors.
    behavioral_mapping: {}
    state_effects: {}
  Macrophage:
    when_active: IL-2 can activate macrophages and promote M1 polarization.
    behavioral_mapping:
      phagocytose: 0.05
    state_effects: {}
  B_cell:
    when_active: IL-2 promotes B cell proliferation and antibody secretion.
    behavioral_mapping:
      proliferate: 0.1
      signal: 0.1
    state_effects:
      antibody_secretion: 0.1
crosstalk:
- pathway: CTLA4_CD28
  type: downstream_target
  description: CD28 costimulation drives IL-2 production; CTLA-4 suppresses it
- pathway: PD1_PDL1
  type: antagonistic
  description: PD-1 signaling reduces IL-2 production by T cells
- pathway: TGFB_SMAD
  type: antagonistic
  description: TGF-beta opposes IL-2-driven T cell expansion
targeted_by: []
references:
- description: IL-2 signaling in T cell expansion. Boyman & Sprent. Nat Rev Immunol
    2012
  pmid: '22564618'
  pmid_verified: true
- description: Foxp3+ CD25+ CD4+ natural regulatory T cells. Sakaguchi et al. Immunol
    Rev 2006
  pmid: '16903903'
  pmid_verified: true
additional_agents:
- drug_id: aldesleukin
  mechanism: Recombinant IL-2 (high-dose immunotherapy)
  in_drug_library: false
data_calibration:
  source: GSE176078 TNBC scRNA-seq (CellChat-lite)
  n_cells: 997
  communication_strength: 0.0023
  max_communication_strength: 0.0031
  n_active_pairs: 2
  top_interactions:
  - sender: CD8_T
    receiver: Treg
    ligand: IL2
    receptor: IL2RA
    probability: 0.0031
  - sender: CD8_T
    receiver: CD8_T
    ligand: IL2
    receptor: IL2RA
    probability: 0.0014
